Delivery Order SPE2DB24D1104-SPE2DB25FXUB3
Award Date
11/1/24
Potential Completion Date
11/25/24
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 0.25 ML doses of the Moderna COVID-19 vaccine for individuals aged 6 months to 11 years, under the Emergency Use Authorization (EUA). The contract, valued at $7,384.40, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division on June 3, 2024, with a completion date of June 25, 2024. The contract is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency, on a Firm Fixed Price basis. It is not designated...
This federal contract award is for the delivery of 0.25 mL doses of the Moderna COVID-19 vaccine for the 6-month to 11-year age group under the Emergency Use Authorization (EUA). The $1,290.00 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 30, 2024 and does not have a set-aside designation, indicating...
This is a $2,580.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. for the provision of 0.25mL doses of the Moderna COVID-19 vaccine for children aged 6 months to 11 years, under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of February 6, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award, valued at $1,908.33, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA), with an ultimate completion date of November 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of Moderna COVID-19 vaccine doses (0.25 mL) for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA). The $1,476.88 firm-fixed-price Delivery Order was awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA), a major U.S. Department of Defense (DoD) agency responsible for providing logistics and acquisition support to the U.S. Armed Forces. Amerisourcebergen, a large...
This federal contract award is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group, under a Delivery Order (DO) placed against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $25,283.10, was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of November 28, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora,...
This federal contract award is for the delivery of Moderna COVID-19 vaccines (0.25 mL dose) for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The $12,800.00 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 23, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This contract award is for the delivery of Moderna COVID-19 vaccines (0.25 mL) for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The contract, valued at $3,797.30, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This is a firm fixed price delivery order contract that does not have a...
The U.S. Defense Logistics Agency (DLA) awarded a $2,215.32 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). This contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical...
This federal contract award, valued at $16,888.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.25mL doses of the Moderna COVID-19 vaccine for individuals aged 6 months to 11 years, under the Emergency Use Authorization (EUA). The award has an ultimate completion date of October 20, 2023. This contract is a delivery order with a firm fixed-price...